Back to Search
Start Over
Metabolomic profile of plasma approach to investigate the mechanism of Poria cocos oligosaccharides attenuated LPS-induced acute lung injury in mice.
- Source :
-
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Sep 01; Vol. 247, pp. 116262. Date of Electronic Publication: 2024 May 29. - Publication Year :
- 2024
-
Abstract
- Poria cocos (Schw.) Wolf (PCW) are the dried sclerotia of Poaceae fungus Poria cocos that contain many biological activity ingredients such as polysaccharides and triterpenoids. The carbohydrates from Poria cocos have been proven to possess anti-inflammatory and antioxidant effects. This study aimed to investigate the impact and mechanism of Poria cocos oligosaccharides (PCO) protecting mice against acute lung injury (ALI). We examined the histopathological analysis of lung injury, inflammatory, and edema levels to evaluate the benefits of PCO during ALI. As a result, PCO improved the lipopolysaccharide (LPS) induced lung injury and decreased the inflammatory cytokines of lung tissue. Simultaneously, PCO alleviated lung edema by regulating the expression of aquaporin5 (AQP5) and epithelial Na <superscript>+</superscript> channel protein (ENaC-α). Additionally, untargeted metabolomics was performed on the plasma of ALI mice via HUPLC-Triple-TOF/MS. The results indicated that linoleic acid, linolenic acid, arachidonic acid, carnosine, glutamic acid, and 1-methylhistamine were the biomarkers in ALI mice. Besides, metabolic pathway analysis suggested PCO affected the histidine and fatty acid metabolism, which were closely associated with inflammation and oxidative reaction of the host. Consequently, the effects of PCO inhibiting inflammation and edema might relate to the reducing pro-inflammatory mediators and the reverse of abnormal metabolic pathways.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Mice
Male
Anti-Inflammatory Agents pharmacology
Biomarkers blood
Disease Models, Animal
Cytokines metabolism
Lung drug effects
Lung metabolism
Lung pathology
Inflammation drug therapy
Inflammation metabolism
Antioxidants pharmacology
Acute Lung Injury chemically induced
Acute Lung Injury metabolism
Acute Lung Injury drug therapy
Metabolomics methods
Lipopolysaccharides toxicity
Oligosaccharides pharmacology
Wolfiporia chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 1873-264X
- Volume :
- 247
- Database :
- MEDLINE
- Journal :
- Journal of pharmaceutical and biomedical analysis
- Publication Type :
- Academic Journal
- Accession number :
- 38820835
- Full Text :
- https://doi.org/10.1016/j.jpba.2024.116262